Pricing Log in Create free account

Cellectar Biosciences, Inc. (CLRB) vs Lisata Therapeutics, Inc. (LSTA)

Cellectar Biosciences, Inc. and Lisata Therapeutics, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. and Lisata Therapeutics, Inc. are of similar size ($10.9M and $10.7M). Across the 9 metrics below, Lisata Therapeutics, Inc. leads on 5 and Cellectar Biosciences, Inc. on 4.

Valuation

Metric CLRB LSTA Biotechnology median
P/E n/m n/m 10.26
P/S n/m 0.60 9.18
P/B 0.48 1.15 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.83 n/m 0.65
EV/Sales n/m 0.13 8.98
Earnings yield (395.97%) (162.38%) (34.89%)
Free cash flow yield (137.75%) (134.29%) (24.52%)

Profitability

Metric CLRB LSTA Biotechnology median
Gross margin 0.00% 0.49% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (125.99%) (101.66%) (50.12%)
Return on assets (88.70%) (80.81%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLRB LSTA Biotechnology median
Revenue growth (TTM) — (24.67%) 6.26%
EPS growth (last fiscal year) 80.07% 20.42% 29.88%
Revenue growth, 5-year CAGR — (20.28%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLRB LSTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.66 3.69 4.89
Net debt to EBITDA 0.58 0.88 1.01

Dividend

Metric CLRB LSTA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLRB LSTA Biotechnology median
Market cap 10.87m 10.71m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack